Aiosyn develops, integrates and certifies AI solutions that empower pathologists to make their clinical decisions in a more accurate, efficient and effective way, for the benefit of patients and society.
We are thrilled and excited to have been selected for the first edition of Techleap’s Pole Position. This new initiative will help us grow faster by providing access to the best network of medtech experts and investors, as well as by facilitating peer-to-peer learning throughout a number of interactive sessions. We look forward to expanding our knowledge and network in the following months with Pole Position!
We hereby also introduce our new company name: Aiosyn. This name highlights our aim to develop explainable AI in synergy with pathologists.
More information about Pole Position can be found here.